Incidence rate of type 1 diabetes significantly increased after COVID-19 infection<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, July 18, 2024 (HealthDay News) — For youth with presymptomatic type 1 diabetes, the COVID-19 pandemic was associated with accelerated progression to clinical disease, especially among those with COVID-19 infection, according to a research letter published online July 15 in the Journal of the American Medical Association<\/em>.<\/p>\n Nadine Friedl, from the Institute of Diabetes Research at Helmholtz Munich, and colleagues examined the potential association between COVID-19 infection and progression to clinical diabetes in youth with presymptomatic type 1 diabetes. Data were obtained for 591 youth, 509 of whom were included in the follow-up. Of these, 358 were followed during the prepandemic period (prior to March 1, 2020) and 396 were followed from March 1, 2020 (pandemic).<\/p>\n The researchers found that type 1 diabetes developed in 57 and 113 participants during the prepandemic and pandemic periods, respectively. For the development of clinical type 1 diabetes, the incidence rate was 6.4 and 12.1 per 100 person-years in the prepandemic and pandemic periods, respectively, yielding an incidence rate ratio of 1.9. Overall, 353 of the 396 participants followed since the pandemic had COVID-19 infection information; of these, 236 had a COVID-19 infection. During the pandemic period, the incidence rates of type 1 diabetes were 8.6 while participants had tested negative for COVID-19 and 14.0 after COVID-19 infection.<\/p>\n “The findings are consistent with previously reported acceleration of progression in children with presymptomatic type 1 diabetes by viral infection,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n